Today's Information |
Provided by: PharmaEngine, Inc. | |||||
SEQ_NO | 12 | Date of announcement | 2022/05/27 | Time of announcement | 18:30:09 |
Subject | Announcement of the 2022 shareholders' meeting resolution of new-elected 9 directors (including 3 independent directors) | ||||
Date of events | 2022/05/27 | To which item it meets | paragraph 6 | ||
Statement | 1.Date of occurrence of the change:2022/05/27 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor):Institutional director, independent director, natural-person director 3.Title and name of the previous position holder: Independent Directors: Chien-Huang Lin, Chih-Li Wang, Sonny Wang Directors: Ming-Feng Hou Directors: Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu, Wen-Hwa Chang, Rui-Wen Wu Legal Representative of National Development Fund, Executive Yuan: Chi-Ying Huang, Yi-Hui Lin 4.Resume of the previous position holder: Wen-Hwa Chang: Vice Chairman, TTY Biopharm Co., Ltd Sonny Wang: Ex-Secretary, Taiwan Corporate Governance Association Chi-Ying Huang: Chairman, Institute of Biopharmaceutical Sciences National Yang-Ming University Chien-Huang Lin: President, Taipei Medical University Ming-Feng Hou: Professor, Surgery-Kaohsiung Medical University Chung-Ho Memorial Hospital Chih-Li Wang: Accountant, Moores Rowland CPAs Ted Tu: Chairman, PharmaEngine, Inc Rui-Wen Wu: Special Assistant of Chairman, TTY Biopharm Co., Ltd Yi-Hui Lin: Director, Audit Affairs at National Development Fund, Executive Yuan. 5.Title and name of the new position holder: Independent Directors: Chien-Huang Lin, Ming-Daw Chang, Chih-Li Wang Directors: Ming-Feng Hou Directors: Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu, Wen-Hung Hsu, Rui-Wen Wu Legal Representative of National Development Fund, Executive Yuan: Ming-Shiang Wu, Yi-Hui Lin 6.Resume of the new position holder: Chien-Huang Lin: President, Taipei Medical University Ming-Daw Chang: Chairman, Bank of Panhsin Chih-Li Wang: Accountant, Moores Rowland CPAs Ming-Feng Hou: Professor, Surgery-Kaohsiung Medical University Chung-Ho Memorial Hospital Ted Tu: Chairman, PharmaEngine, Inc Wen-Hung Hsu: Senior Vice President & Co-founder , WT MICROELECTRONICS Rui-Wen Wu: Special Assistant of Chairman, TTY Biopharm Co., Ltd Ming-Shiang Wu: Superintendent, National Taiwan University Hospital Yi-Hui Lin: Director, Audit Affairs at National Development Fund, Executive Yuan. 7.Circumstances of change (Please enter "resignation", "dismissal", "term expired", "death" or "new appointment"):tenure expired 8.Reason for the change:tenure expired 9.Number of shares held by the new position holder when elected: (1) Independent Director: Chien-Huang Lin: 0 shares (2) Independent Director: Ming-Daw Chang: 0 shares (3) Independent Director: Chih-Li Wang: 3,021 shares (4) Director: Ming-Feng Hou: 0 shares (5) Director: TTY Biopharm Co., Ltd. : 25,866,808 shares (6) Director: National Development Fund, Executive Yuan: 22,585,654 shares (7) Director: Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu: 30,000 shares 10.Original term (from __________ to __________):108/06/13~111/06/12 11.Effective date of the new appointment:2022/05/27 12.Turnover rate of directors of the same term:N/A 13.Turnover rate of independent directors of the same term:N/A 14.Turnover rate of supervisors of the same term:N/A 15.Change in one-third or more of directors (Please enter "Yes" or "No"):No 16.Any other matters that need to be specified:None |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
PharmaEngine Inc. published this content on 27 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 May 2022 10:41:57 UTC.